← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 31, 2018Last known activity
Apr 30, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT04362527Overall official - principal investigatorPhase 3Apr 30, 2020
- NCT03311516CollaboratorN/AOct 31, 2018
Details
- Last known activity
- Apr 30, 2020